Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.

Pubmed ID: 26681712

Pubmed Central ID: PMC4806772

Journal: Diabetes care

Publication Date: April 1, 2016

MeSH Terms: Humans, Male, Female, Cardiovascular Diseases, Risk Factors, Middle Aged, Body Mass Index, Proportional Hazards Models, Prospective Studies, Prognosis, Follow-Up Studies, Kidney Failure, Chronic, Incidence, Diabetes Mellitus, Blood Glucose, Hyperglycemia, Serum Albumin, Biomarkers, Fructosamine, Glycation End Products, Advanced, Deoxyglucose, Racial Groups, Glycated Hemoglobin, Glycated Serum Albumin

Grants: HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01 DK089174, T32 HL007024, K24 DK106414, HHSN268201100009I, HHSN268201100005G, HHSN268201100008I, HHSN268201100011I, HHSN268201100005I, HHSN268201100007I

Authors: Coresh J, Grams ME, Selvin E, Sharrett AR, Parrinello CM, Maruthur NM, Bergenstal RM

Cite As: Parrinello CM, Sharrett AR, Maruthur NM, Bergenstal RM, Grams ME, Coresh J, Selvin E. Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia. Diabetes Care 2016 Apr;39(4):589-95. Epub 2015 Dec 17.

Studies:

Abstract

OBJECTIVE: We compared levels and associations of traditional (fasting glucose, HbA1c) and nontraditional (fructosamine, glycated albumin, and 1,5-anhydroglucitol [1,5-AG]) biomarkers of hyperglycemia with incident cardiovascular disease (CVD), incident end-stage renal disease (ESRD), and prevalent retinopathy in black and white adults. RESEARCH DESIGN AND METHODS: We included 10,373 participants without (8,096 white, 2,277 black) and 727 with diagnosed diabetes (425 white, 302 black) from the Atherosclerosis Risk in Communities (ARIC) Study. We used Cox proportional hazards models to compare hazards ratios of CVD and ESRD among blacks and whites from baseline (1990-1992) through 2012. We compared the odds ratios (from logistic regression) of retinopathy among blacks and whites. We tested for the interaction of each biomarker with race. RESULTS: Median values of biomarkers were higher among blacks versus whites (all P < 0.001). Relative risks for each biomarker with incident CVD and ESRD, and odds ratios for each biomarker with prevalent retinopathy, were similar by race (all P values for interaction by race >0.10). CONCLUSIONS: The prognostic value of HbA1c, fructosamine, glycated albumin, and 1,5-AG with incident CVD, incident ESRD, and prevalent retinopathy were similar by race. Our results support similar interpretation of HbA1c and nontraditional biomarkers of hyperglycemia among black and whites with respect to long-term complications.